BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21971015)

  • 21. Difference in methylation patterns within the D15S9 region of chromosome 15q11-13 in first cousins with Angelman syndrome and Prader-Willi syndrome.
    Clayton-Smith J; Driscoll DJ; Waters MF; Webb T; Andrews T; Malcolm S; Pembrey ME; Nicholls RD
    Am J Med Genet; 1993 Oct; 47(5):683-6. PubMed ID: 8266996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint.
    Schulze A; Hansen C; Skakkebaek NE; Brøndum-Nielsen K; Ledbeter DH; Tommerup N
    Nat Genet; 1996 Apr; 12(4):452-4. PubMed ID: 8630505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epilepsy in Prader-Willi syndrome: clinical characteristics and correlation to genotype.
    Vendrame M; Maski KP; Chatterjee M; Heshmati A; Krishnamoorthy K; Tan WH; Kothare SV
    Epilepsy Behav; 2010 Nov; 19(3):306-10. PubMed ID: 20727826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models of Prader-Willi Syndrome: a systematic review.
    Bervini S; Herzog H
    Front Neuroendocrinol; 2013 Apr; 34(2):107-19. PubMed ID: 23391702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extreme obesity in Prader-Willi Syndrome (PWS)].
    Damiano J; Ficko C; Garrabé E; Mayaudon H; Dupuy O; Carmoi T; Bordier L; Bauduceau B
    Rev Med Interne; 2003 Sep; 24(9):617-20. PubMed ID: 12951183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation studies of SNRPN methylation as a diagnostic test for Prader-Willi syndrome.
    Kubota T; Sutcliffe JS; Aradhya S; Gillessen-Kaesbach G; Christian SL; Horsthemke B; Beaudet AL; Ledbetter DH
    Am J Med Genet; 1996 Dec; 66(1):77-80. PubMed ID: 8957518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models for Prader-Willi syndrome.
    Zahova S; Isles AR
    Handb Clin Neurol; 2021; 181():391-404. PubMed ID: 34238473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical spectrum and molecular diagnosis of Angelman and Prader-Willi syndrome patients with an imprinting mutation.
    Saitoh S; Buiting K; Cassidy SB; Conroy JM; Driscoll DJ; Gabriel JM; Gillessen-Kaesbach G; Glenn CC; Greenswag LR; Horsthemke B; Kondo I; Kuwajima K; Niikawa N; Rogan PK; Schwartz S; Seip J; Williams CA; Nicholls RD
    Am J Med Genet; 1997 Jan; 68(2):195-206. PubMed ID: 9028458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice.
    Chamberlain SJ; Johnstone KA; DuBose AJ; Simon TA; Bartolomei MS; Resnick JL; Brannan CI
    Hum Mol Genet; 2004 Dec; 13(23):2971-7. PubMed ID: 15459179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding.
    McAllister CJ; Whittington JE; Holland AJ
    Int J Obes (Lond); 2011 Feb; 35(2):188-97. PubMed ID: 20680019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficits in voice and multisensory processing in patients with Prader-Willi syndrome.
    Salles J; Strelnikov K; Carine M; Denise T; Laurier V; Molinas C; Tauber M; Barone P
    Neuropsychologia; 2016 May; 85():137-47. PubMed ID: 26994593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.
    Adhikari A; Copping NA; Onaga B; Pride MC; Coulson RL; Yang M; Yasui DH; LaSalle JM; Silverman JL
    Neurobiol Learn Mem; 2019 Nov; 165():106874. PubMed ID: 29800646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric illness and intellectual disability in the Prader-Willi syndrome with different molecular defects--a meta analysis.
    Yang L; Zhan GD; Ding JJ; Wang HJ; Ma D; Huang GY; Zhou WH
    PLoS One; 2013; 8(8):e72640. PubMed ID: 23967326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic diseases: congenital central hypoventilation, Rett, and Prader-Willi syndromes.
    Gallego J
    Compr Physiol; 2012 Jul; 2(3):2255-79. PubMed ID: 23723037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
    Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for the investigation of animal models of Prader-Willi syndrome.
    Resnick JL; Nicholls RD; Wevrick R;
    Mamm Genome; 2013 Jun; 24(5-6):165-78. PubMed ID: 23609791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive and behavioural aspects of Prader-Willi syndrome.
    Rice LJ; Einfeld SL
    Curr Opin Psychiatry; 2015 Mar; 28(2):102-6. PubMed ID: 25599341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognition and behavior in pre-pubertal children with Prader-Willi syndrome and associations with sleep-related breathing disorders.
    Festen DA; Wevers M; de Weerd AW; van den Bossche RA; Duivenvoorden HJ; Hokken-Koelega AC
    Am J Med Genet A; 2008 Dec; 146A(23):3018-25. PubMed ID: 19006209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential of Epigenetic Therapy for Prader-Willi Syndrome.
    Wang SE; Jiang YH
    Trends Pharmacol Sci; 2019 Sep; 40(9):605-608. PubMed ID: 31353046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Snord116 alters cortical neuronal activity in mice: a preclinical investigation of Prader-Willi syndrome.
    Pace M; Colombi I; Falappa M; Freschi A; Bandarabadi M; Armirotti A; Encarnación BM; Adamantidis AR; Amici R; Cerri M; Chiappalone M; Tucci V
    Hum Mol Genet; 2020 Jul; 29(12):2051-2064. PubMed ID: 32426821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.